Induction of Multiple Drug Transporters by Efavirenz
Efavirenz, an important component of human immunodeficiency virus 1 (HIV-1) therapy, causes substantial drug interactions as an inducer of cytochromes and the transporter ABCB1. So far its effect on the expression of other transporters is unknown. We therefore investigated the effect of long-term ex...
Main Authors: | Johanna Weiss, Melanie Herzog, Sonja König, Caroline Henrike Storch, Nahal Ketabi-Kiyanvash, Walter Emil Haefeli |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2009-01-01
|
Series: | Journal of Pharmacological Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861319312794 |
Similar Items
-
Interaction Potential of the Multitargeted Receptor Tyrosine Kinase Inhibitor Dovitinib with Drug Transporters and Drug Metabolising Enzymes Assessed in Vitro
by: Johanna Weiss, et al.
Published: (2014-12-01) -
Interaction of Hydroxychloroquine with Pharmacokinetically Important Drug Transporters
by: Johanna Weiss, et al.
Published: (2020-09-01) -
Efavirenz in pregnancy
by: Polly Clayden, et al.
Published: (2010-11-01) -
Modelling Transportation of Efavirenz: Inference on possibility of mixed modes of transportation and kinetic solubility
by: Tafireyi eNemaura, et al.
Published: (2015-06-01) -
Efavirenz-induced urolithiasis.
by: Wirth, G, et al.
Published: (2006)